| Code | 3032E | ||||||||||
| MA number | EU/1/22/1710/002 | ||||||||||
| Product Form: | sol inj 3x3 ml/750 µg (zásobník skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Strides Pharma (Cyprus) Limited, Cyprus | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(4) similar biological application |
| MA issued: | 12.01.2023 |
| Validity: | 12.01.2028 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 21.02.2023 |
